Submitting Clinical Trial Datasets to Evaluate the Impact of Immunogenicity on the Pharmacokinetics of a Drug; Guidance for Industry

NonrulemakingOtherFDA-2017-D-6821-0030
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 18, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets